Cradle

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

Articul8 is a GenAI platform designed to bring order to chaos by enabling users to build sophisticated enterprise applications using their expertise. It offers features such as autonomous decision-making, automated data intelligence, and a library of specialized models. The platform aims to provide faster time to ROI, improved accuracy, and precision, along with rich semantic understanding of data. Articul8 is engineered for regulated industries and offers observability, traceability, and auditability at every step.

Patee.io is an AI-powered platform that helps businesses automate their data annotation and labeling tasks. With Patee.io, businesses can easily create, manage, and annotate large datasets, which can then be used to train machine learning models. Patee.io offers a variety of features that make it easy to annotate data, including a user-friendly interface, a variety of annotation tools, and the ability to collaborate with others. Patee.io also offers a number of pre-built models that can be used to automate the annotation process, saving businesses time and money.

Fathom5 is a company that specializes in the intersection of AI and industrial systems. They offer a range of products and services to help customers build more resilient, flexible, and efficient industrial systems. Fathom5's approach is unique in that they take a security-first approach to cyber-physical system design. This means that security is built into every stage of the development process, from ideation to engineering to testing to deployment. This approach has been proven to achieve higher system resiliency and faster regulatory compliance at a reduced cost.

Wild Moose is an AI-powered SRE Copilot tool designed to help companies handle incidents efficiently. It offers fast and efficient root cause analysis that improves with every incident by automatically gathering and analyzing logs, metrics, and code to pinpoint root causes. The tool converts tribal knowledge into custom playbooks, constantly improves performance with a system model that learns from each incident, and integrates seamlessly with various observability tools and deployment platforms. Wild Moose reduces cognitive load on teams, automates routine tasks, and provides actionable insights in real-time, enabling teams to act fast during outages.

Bash Senpai is a terminal assistant powered by ChatGPT that transforms instructions into ready-to-use commands. It provides convenience by allowing users to get answers without leaving the terminal and offers better answers by providing context with questions. The tool also incorporates self-reflection to improve the quality of its responses.

Clearbit is a B2B marketing intelligence platform that provides data enrichment, scoring, routing, and buying intent signals. It is powered by artificial intelligence and is the first HubSpot Native Data Provider. Clearbit's data foundation is built on public data from the web, proprietary data, and the power of LLMs to convert unstructured information into precise and standardized data sets. This data can be used to enrich leads, contacts, and accounts, and to identify hidden buying intent. Clearbit also offers a variety of features to help businesses score and route leads, and to create better converting forms.

Stately is a visual logic builder that enables users to create complex logic diagrams and code in minutes. It provides a drag-and-drop editor that brings together contributors of all backgrounds, allowing them to collaborate on code, diagrams, documentation, and test generation in one place. Stately also integrates with AI to assist in each phase of the development process, from scaffolding behavior and suggesting variants to turning up edge cases and even writing code. Additionally, Stately offers bidirectional updates between code and visualization, allowing users to use the tools that make them most productive. It also provides integrations with popular frameworks such as React, Vue, and Svelte, and supports event-driven programming, state machines, statecharts, and the actor model for handling even the most complex logic in predictable, robust, and visual ways.

Kira Systems is a machine learning contract search, review, and analysis software that helps businesses identify, extract, and analyze content in their contracts and documents. It uses patented machine learning technology to extract concepts and data points with high efficiency and accuracy. Kira also has built-in intelligence that streamlines the contract review process with out-of-the-box smart fields. Businesses can also create their own smart fields to find specific data points using Kira's no-code machine learning tool. Kira's adaptive workflows allow businesses to organize, track, and export results. Kira has a partner ecosystem that allows businesses to transform how teams work with their contracts.

Extractify.co is a website that offers a variety of tools and services for extracting information from different sources. The platform provides users with the ability to extract data from websites, documents, and other sources in a quick and efficient manner. With a user-friendly interface, Extractify.co aims to simplify the process of data extraction for individuals and businesses alike. Whether you need to extract text, images, or other types of data, Extractify.co has the tools to help you get the job done. The platform is designed to be intuitive and easy to use, making it accessible to users of all skill levels.

Vidrovr is a video analysis platform that uses machine learning to process unstructured video, image, or audio data. It provides business insights to help drive revenue, make strategic decisions, and automate monotonous processes within a business. Vidrovr's technology can be used to minimize equipment downtime, proactively plan for equipment replacement, leverage AI to empower mission objectives and decision making, monitor persons or topics of interest across various media sources, ensure critical infrastructure is monitored 24/7/365, and protect ecological assets.

AdminIQ is an AI-powered site reliability platform that helps businesses improve the reliability and performance of their websites and applications. It uses machine learning to analyze data from various sources, including application logs, metrics, and user behavior, to identify and resolve issues before they impact users. AdminIQ also provides a suite of tools to help businesses automate their site reliability processes, such as incident management, change management, and performance monitoring.

Recall is an AI-driven application that allows users to summarize and save any online content to their knowledge base. It automatically organizes and interlinks the saved content for easy rediscovery. Users can summarize podcasts, YouTube videos, news articles, PDFs, and more, and the application categorizes the content based on its mentions. Recall also helps users discover connections between different pieces of content by saving them in a knowledge graph. The application is praised by professionals for its AI-driven summarization and storage capabilities, boosting productivity and facilitating easy access to key details.

Summarizer is a Chrome extension that allows users to summarize articles and webpages quickly and efficiently. With this tool, users can extract key information from lengthy texts, saving time and enhancing productivity. The extension provides concise summaries that capture the main points of the content, making it easier for users to grasp the essential details without having to read through the entire text. Summarizer is a valuable tool for students, researchers, professionals, and anyone who needs to process large amounts of information in a short time.

ABtesting.ai is an AI-powered A/B testing software that helps businesses optimize their landing pages for conversions. It uses GPT-3 to generate automated text suggestions for headlines, copy, and call to actions, saving businesses time and effort. The software also automatically chooses the best combinations of elements to show to users, boosting conversion rates in the process. ABtesting.ai is easy to use and requires no manual work, making it a great option for businesses of all sizes.

Superlinked is a compute framework for your information retrieval and feature engineering systems, focused on turning complex data into vector embeddings. Vectors power most of what you already do online - hailing a cab, finding a funny video, getting a date, scrolling through a feed or paying with a tap. And yet, building production systems powered by vectors is still too hard! Our goal is to help enterprises put vectors at the center of their data & compute infrastructure, to build smarter and more reliable software.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health. The platform is trusted by partners in precision health and medicine and is continuously evolving to disrupt drug discovery times and costs at all stages.

PubCompare is a powerful AI-powered tool that helps scientists search, compare, and evaluate experimental protocols. With over 40 million protocols in its database, PubCompare is the largest repository of trusted experimental protocols. PubCompare's AI-powered search features allow users to find similar protocols, highlight critical steps, and evaluate the reproducibility of protocols based on in-protocol citations. PubCompare is available from any computer and requires no download.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Deep Genomics is a company that uses artificial intelligence (AI) to develop RNA therapies for genetic diseases. The company's AI platform is designed to identify novel targets and evaluate thousands of possibilities to identify the best therapeutic candidates. Deep Genomics is currently developing BigRNA+, which will expand the number of mechanisms and genetic variants the company can pursue.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Bionl is a no-code bioinformatics platform designed to streamline biomedical research for researchers and scientists. It offers a full workspace with features such as bioinformatics pipelines customization, GenAI for data analysis, AI-powered literature search, PDF analysis, and access to public datasets. Bionl aims to automate cloud, file system, data, and workflow management for efficient and precise analyses. The platform caters to Pharma and Biotech companies, academic researchers, and bioinformatics CROs, providing powerful tools for genetic analysis and speeding up research processes.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

HoloEye.AI is a transformative AI biological intelligence company that leverages cutting-edge artificial intelligence technology to revolutionize the field of biological research. The platform offers advanced AI solutions for analyzing complex biological data, enabling researchers to gain deeper insights and accelerate scientific discoveries.

Mapmygenome is an AI-powered platform that offers DNA testing products for health, fitness, and beauty. It provides personalized insights based on genetic analysis to help individuals make informed decisions about their health, wellness, and lifestyle choices. With over 23 years of genomics experience and the latest sequencing technology, Mapmygenome aims to empower users to take proactive steps towards improving their overall well-being.

Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

Lavo Life Sciences is an AI-accelerated crystal structure prediction application that helps in drug development by providing accurate predictions for small molecule drugs. The application utilizes AI technology to optimize solid-state formulations, reduce turnaround time, mitigate risks, and discover novel polymorphs, ultimately streamlining the pharmaceutical research and development process.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

Allchemy is a resource-aware AI platform for drug discovery. It combines state-of-the-art computational synthesis with AI algorithms to predict molecular properties. Within minutes, Allchemy creates thousands of synthesizable lead candidates meeting user-defined profiles of drug-likeness, affinity towards specific proteins, toxicity, and a range of other physical-chemical measures. Allchemy encompasses the entire resource-to-drug design process and has been used in academic, corporate and classified environments worldwide to: Design synthesizable leads targeting specific proteins Evolve scaffolds similar to desired drugs Design “circular” drug syntheses from renewable materials Interface with and instruct automated synthesis platforms and optimize pilot-scale processes Operate “iterative synthesis” schemes Predict side reactions and create forensic “synthetic signatures” of hazardous/toxic molecules Design synthetic degradation and recovery cycles for various types of feedstocks and functional target molecules

C&EN, a publication of the American Chemical Society, provides the latest news and insights on the chemical industry, including research, technology, business, and policy. It covers a wide range of topics, including analytical chemistry, biological chemistry, business, careers, education, energy, environment, food, materials, people, pharmaceuticals, physical chemistry, policy, research integrity, safety, and synthesis.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Owkin is a full-stack AI biotech company that integrates the best of human and artificial intelligence to deliver better drugs and diagnostics at scale. By understanding complex biology through AI, Owkin identifies new treatments, de-risks and accelerates clinical trials, and builds diagnostic tools to reduce time to impact for patients.

Cerebras is an AI tool that offers products and services related to AI supercomputers, cloud system processors, and applications for various industries. It provides high-performance computing solutions, including large language models, and caters to sectors such as health, energy, government, scientific computing, and financial services. Cerebras specializes in AI model services, offering state-of-the-art models and training services for tasks like multi-lingual chatbots and DNA sequence prediction. The platform also features the Cerebras Model Zoo, an open-source repository of AI models for developers and researchers.

CCDS (Center for Computational & Data Sciences) is a research center at Independent University Bangladesh dedicated to artificial intelligence, data sciences, and computational science. The center has various wings focusing on AI, computational biology, physics, data science, human-computer interaction, and industry partnerships. CCDS explores the use of computation to understand nature and society, uncover hidden stories in data, and tackle complex challenges. The center collaborates with institutions like CERN and the Dunlap Institute for Astronomy and Astrophysics.